Clinical Trials Directory

Trials / Completed

CompletedNCT03498742

Asthmatic Subjects Could Live Without Short Acting beta2 Agonists

Asthmatic Subjects Could Live Without Short Acting Beta2 Agonists (SABA)

Status
Completed
Phase
Study type
Observational
Enrollment
86 (actual)
Sponsor
Universidad Nacional de Rosario · Academic / Other
Sex
All
Age
16 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Since 2006 there was a plateau in world wide mortality from asthma. Overreliance in Short Acting Beta2 Agonists (SABA) was associated with increased risk of death from asthma. Long acting beta agonists (LABA) alone was not permitted as treatment for asthma as it was determined by FDA by the "black box". By contrast SABA does not have a "black box", despite similar overuse alerts associated with increased risk of death from asthma. the investigators want to know if exist asthmatic subjects that do use another rescue medication; not SABA, and to compare their features, Asthma Control Test (ACT), and lung function in a outpatient facility. First consecutive visits at outpatient Pulmonary Section of asthmatic subjects were described. Asthma Control Test (ACT) that was routinely used to assess asthma and spirometry were performed.

Detailed description

During the period from March 10, 2017 to January 16, 2018 the investigators decided to describe the rescue medication in all new asthmatic subjects that came for a first visit to the outpatient pulmonary department. Patients aged ≥16 years were entered in the study with a a diagnosis of asthma, based on a history of episodic dyspnea and wheezing, and/or documented bronchodilator reversibility in forced expiratory volume in 1 s (FEV1) of 12% and 200 ml according to the National Institutes of Health criteria; to be non- or ex-smoker of less than 10 pack-yr, to be neither pregnant nor breast-feeding and to be capable of completing Asthma control test and spirometry. Consecutive patients visiting the outpatient pulmonary department were included in the description.

Conditions

Interventions

TypeNameDescription
OTHERNO InterventionRoutine clinical data; asthma control test and spirometry

Timeline

Start date
2017-03-10
Primary completion
2018-01-16
Completion
2018-01-16
First posted
2018-04-17
Last updated
2018-04-17

Locations

1 site across 1 country: Argentina

Source: ClinicalTrials.gov record NCT03498742. Inclusion in this directory is not an endorsement.

Asthmatic Subjects Could Live Without Short Acting beta2 Agonists (NCT03498742) · Clinical Trials Directory